• OPEN AN ACCOUNT
Indian Indices
Sensex
84,233.64 -40.28
( -0.05%)
Global Indices
Nasdaq
50,215.24 58.36
(0.12%)
Dow Jones
6,964.30 -21.52
(-0.31%)
Hang Seng
57,678.97 1,315.03
(2.33%)
Nikkei 225
10,491.19 137.35
(1.33%)
Forex
USD-INR
90.66 0.22
(0.24%)
EUR-INR
107.64 0.80
(0.75%)
GBP-INR
123.65 0.62
(0.51%)
JPY-INR
0.58 0.00
(0.85%)

EQUITY - MARKET SCREENER

Beryl Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524606
INE415H01017
18.6259045
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
47.13
11
EPS(TTM)
Face Value()
Div & Yield %
0.46
10
0
 

L&T gains on bagging 'significant' road development contract in Dubai
Feb 10,2026
The contract has been classified as 'significant', implying an order value in the range of Rs 1,000 crore to Rs 2,500 crore.

The order relates to Phase I of the improvement of Latifa Bint Hamdan Street, awarded by UAE authorities. The project involves upgrading the existing corridor from Emirates Road (E611) to Sheikh Mohammed Bin Zayed Road (E311) by widening the current two-lane dual carriageway into a four-lane dual carriageway in each direction to improve traffic capacity and flow.

The scope also includes construction of a major structural interchange at E311 to enable seamless traffic movement in all directions, extension of the corridor with a new four-lane dual carriageway, and a dedicated interchange to facilitate U-turns and improve access to adjoining developments. The project is scheduled for completion within 36 months.

L&T is an Indian multinational engaged in EPC projects, hi-tech manufacturing, and services, operating across multiple geographies.

On a consolidated basis, L&T's net profit declined 4.27% year-on-year to Rs 3,215.11 crore in Q3 FY26, even as revenue from operations rose 10.48% to Rs 71,449.70 crore in Q3 FY26.